Salvavidas Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.15 M
as on 30-11-2024
- Paid Up Capital ₹ 0.13 M
as on 30-11-2024
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 22.55%
(FY 2024)
- Profit 11.63%
(FY 2024)
- Ebitda 34.14%
(FY 2024)
- Net Worth 80.87%
(FY 2024)
- Total Assets 25.75%
(FY 2024)
About Salvavidas Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.15 M and a paid-up capital of Rs 0.13 M, as per Ministry of Corporate Affairs (MCA) records.
Kaushik Dobariya, Rajesh Tala, Viral Dhaduk, and One other member serve as directors at the Company.
- CIN/LLPIN
U74140GJ2015PTC085028
- Company No.
085028
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Nov 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Salvavidas Pharmaceutical Private Limited offer?
Salvavidas Pharmaceutical Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Laxatives, Common Disease Medicines, Pharmaceutical Syrup, Allopathic Cough Syrup, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Dietary Supplements, Anti Infective Drugs & Medicines, Antiparasitic Drug.
Who are the key members and board of directors at Salvavidas Pharmaceutical?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Tala  | Director | 09-Nov-2015 | Current |
| Kaushik Dobariya | Director | 09-Nov-2015 | Current |
| Viral Dhaduk | Director | 09-Nov-2015 | Current |
| Sunil Sanghani | Director | 06-Apr-2023 | Current |
Financial Performance of Salvavidas Pharmaceutical.
Salvavidas Pharmaceutical Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 22.55% increase. The company also saw a substantial improvement in profitability, with a 11.63% increase in profit. The company's net worth Soared by an impressive increase of 80.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Salvavidas Pharmaceutical?
Unlock access to Salvavidas Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Salvavidas Wellness Private LimitedActive 5 years 3 monthsKaushik Dobariya, Rajesh Tala and 2 more are mutual person
Salvavidas Pharmachem Private LimitedActive 1 year 10 monthsKaushik Dobariya, Rajesh Tala and 2 more are mutual person
- Salvavidas Industries Private LimitedActive 1 year 10 days
Kaushik Dobariya, Rajesh Tala and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Salvavidas Pharmaceutical?
Unlock and access historical data on people associated with Salvavidas Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Salvavidas Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Salvavidas Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
